Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03481556
Title Study of Melflufen + Dex With Bortezomib or Daratumumab in Patients With RRMM (ANCHOR)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Oncopeptides AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
Fakultní nemocnice Brno Brno Czechia Details
Fakultní nemocnice Hradec Králové Hradec Králové Czechia Details
Fakultní nemocnice Ostrava Ostrava Czechia Details
Všeobecná fakultní nemocnice Praha Czechia Details
Hôpital Morvan Brest France Details
Centre Jean Bernard - Clinique Victor Hugo Le Mans France Details
Hôpital privé du Confluent Nantes France Details
Centre Hospitalier Lyon Sud Pierre-Bénite France Details
Centre Hospitalier Universitaire Institut Gustave Roussy Villejuif France Details
Hospital Universitai Germans Trias i Pujol Badalona Spain Details
Hospital de la Santa Creu i Sant Pau Barcelona Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Complejo Hospitalario de Salamanca Salamanca Spain Details
Hospital Universitario Marques de Valdecilla Santander Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field